FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:222-224 January 20, 2005 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Editorial by Kadish, A. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Bardy, G. H. PubMed Citation

The results of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), reported in this issue of the Journal (pages 225–237), show that there are likely to be expanded clinical indications for the use of an implantable cardioverter–defibrillator (ICD) in the prevention of sudden death from cardiac causes. Medicare beneficiaries currently account for 80 percent of such deaths in the United States, and the Center for Medicare and Medicaid Services (CMS) is poised to expand its ICD coverage substantially to reflect the results of this trial. Through this policy decision, CMS will also support the development of further evidence to . . . [Full Text of this Article]

Source Information

Dr. McClellan is the administrator and Dr. Tunis is chief medical officer of the Center for Medicare and Medicaid Services (CMS), Baltimore. Dr. Tunis also directs the Office of Clinical Standards and Quality at CMS.

Related Letters:

Implantable Cardioverter–Defibrillators
Mack M. J., Nash I., van Veldhuisen D. J., Voors A. A., Patwala A., Schlosshan D., Williams S. G., Bardy G. H., Lee K. L., Mark D. B., Kadish A. H., McClellan M. B., Tunis S. R.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:2022-2025, May 12, 2005. Correspondence

This article has been cited by other articles:

• Peterson, P. N., Daugherty, S. L., Wang, Y., Vidaillet, H. J., Heidenreich, P. A., Curtis, J. P., Masoudi, F. A., on behalf of the National Cardiovascular Data Regi, (2009). Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy. Circulation 119: 1078-1084 [Abstract] [Full Text]  
• Kelley, A. S., Mehta, S. S., Carrington Reid, M. (2009). Management of Patients with ICDs at the End of Life (EOL): A Qualitative Study. AM J HOSP PALLIAT CARE 25: 440-446 [Abstract]  
• Myerburg, R. J. (2008). Implantable Cardioverter-Defibrillators after Myocardial Infarction. NEJM 359: 2245-2253 [Full Text]  
• Pellegrini, C. N., Lee, K., Olgin, J. E., Turakhia, M. P., Tseng, Z. H., Lee, R., Badhwar, N., Lee, B., Varosy, P. D. (2008). Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace 10: 1296-1301 [Abstract] [Full Text]  
• Hillner, B. E., Siegel, B. A., Liu, D., Shields, A. F., Gareen, I. F., Hanna, L., Stine, S. H., Coleman, R. E. (2008). Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry. JCO 26: 2155-2161 [Abstract] [Full Text]  
• Hernandez, A. F., Fonarow, G. C., Liang, L., Al-Khatib, S. M., Curtis, L. H., LaBresh, K. A., Yancy, C. W., Albert, N. M., Peterson, E. D. (2007). Sex and Racial Differences in the Use of Implantable Cardioverter-Defibrillators Among Patients Hospitalized With Heart Failure. JAMA 298: 1525-1532 [Abstract] [Full Text]  
• Passman, R., Kadish, A. (2007). Sudden Death Prevention With Implantable Devices. Circulation 116: 561-571 [Full Text]  
• Lee, D. S., Tu, J. V., Austin, P. C., Dorian, P., Yee, R., Chong, A., Alter, D. A., Laupacis, A. (2007). Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation. J Am Coll Cardiol 49: 2408-2415 [Abstract] [Full Text]  
• Lindsay, M. J., Siegel, B. A., Tunis, S. R., Hillner, B. E., Shields, A. F., Carey, B. P., Coleman, R. E. (2007). The National Oncologic PET Registry: Expanded Medicare Coverage for PET Under Coverage with Evidence Development. Am. J. Roentgenol. 188: 1109-1113 [Abstract] [Full Text]  
• Tunis, S. R., Carino, T. V., Williams, R. D. II, Bach, P. B. (2007). Federal Initiatives To Support Rapid Learning About New Technologies. Health Aff (Millwood) 26: w140-w149 [Abstract] [Full Text]  
• Camm, J., Klein, H., Nisam, S. (2007). The cost of implantable defibrillators: perceptions and reality. Eur Heart J 28: 392-397 [Abstract] [Full Text]  
• Chow, T., Kereiakes, D. J., Bartone, C., Booth, T., Schloss, E. J., Waller, T., Chung, E., Menon, S., Nallamothu, B. K., Chan, P. S. (2007). Microvolt T-Wave Alternans Identifies Patients With Ischemic Cardiomyopathy Who Benefit From Implantable Cardioverter-Defibrillator Therapy. J Am Coll Cardiol 49: 50-58 [Abstract] [Full Text]  
• Weisfeldt, M. L., Zieman, S. J. (2007). Advances In The Prevention And Treatment Of Cardiovascular Disease. Health Aff (Millwood) 26: 25-37 [Abstract] [Full Text]  
• Tunis, S. R., Pearson, S. D. (2006). Coverage Options For Promising Technologies: Medicare's 'Coverage With Evidence Development'. Health Aff (Millwood) 25: 1218-1230 [Abstract] [Full Text]  
• Keenan, P. S., Neumann, P. J., Phillips, K. A. (2006). Biotechnology And Medicare's New Technology Policy: Lessons From Three Case Studies. Health Aff (Millwood) 25: 1260-1269 [Abstract] [Full Text]  
• Pearson, S. D., Miller, F. G., Emanuel, E. J. (2006). Medicare's requirement for research participation as a condition of coverage: is it ethical?. JAMA 296: 988-991 [Full Text]  
• Kaufman, S. R., Shim, J. K., Russ, A. J. (2006). Old age, life extension, and the character of medical choice.. Journals of Gerontology Series B: Psychological Sciences and Social Science 61: S175-S184 [Abstract] [Full Text]  
• Marchlinski, F. E., Jessup, M. (2006). Timing the Implantation of Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy. J Am Coll Cardiol 47: 2483-2485 [Full Text]  
• Reynolds, M. R., Cohen, D. J., Kugelmass, A. D., Brown, P. P., Becker, E. R., Culler, S. D., Simon, A. W. (2006). The Frequency and Incremental Cost of Major Complications Among Medicare Beneficiaries Receiving Implantable Cardioverter-Defibrillators. J Am Coll Cardiol 47: 2493-2497 [Abstract] [Full Text]  
• Kadish, A., Schaechter, A., Subacius, H., Thattassery, E., Sanders, W., Anderson, K. P., Dyer, A., Goldberger, J., Levine, J. (2006). Patients With Recently Diagnosed Nonischemic Cardiomyopathy Benefit From Implantable Cardioverter-Defibrillators. J Am Coll Cardiol 47: 2477-2482 [Abstract] [Full Text]  
• Scheinman, M. M., Keung, E. (2006). The Year in Clinical Electrophysiology. J Am Coll Cardiol 47: 1207-1213 [Full Text]  
• Gibbons, R. J., Chareonthaitawee, P., Bailey, K. R. (2006). Revascularization in Systolic Heart Failure: A Difficult Decision. Circulation 113: 180-182 [Full Text]  
• Anderson, K. P., Stevenson, L. W., Stevenson, W. G., Fauchier, L., Babuty, D., Sanders, G. D., Hlatky, M. A., Owens, D. K. (2006). Cost-Effectiveness of ICDs. NEJM 354: 205-207 [Full Text]  
• Myerburg, R. J., Castellanos, A. (2006). Clinical Research Designs and Implantable Defibrillator Indications: Spend in the Beginning or Pay at the End. J Am Coll Cardiol 47: 108-111 [Full Text]  
• (2005). ICDs vs. Amiodarone for Patients with HF and LV Dysfunction. Journal Watch Cardiology 2005: 4-4 [Full Text]  
• Achtelik, M. (2005). Preventing Sudden Cardiac Death. ANN INTERN MED 143: 756-756 [Full Text]  
• Pauker, S. G., Estes, N. A. M., Salem, D. N. (2005). Preventing Sudden Cardiac Death. ANN INTERN MED 143: 756-756 [Full Text]  
• Fisher, J. D. (2005). Who Needs a Defibrillator?: The Beat Goes On. J Am Coll Cardiol 46: 1727-1728 [Full Text]  
• Sanders, G. D., Hlatky, M. A., Owens, D. K. (2005). Cost-Effectiveness of Implantable Cardioverter-Defibrillators. NEJM 353: 1471-1480 [Abstract] [Full Text]  
• Neumann, P. J., Rosen, A. B., Weinstein, M. C. (2005). Medicare and Cost-Effectiveness Analysis. NEJM 353: 1516-1522 [Full Text]  
• Gehi, A., Haas, D., Fuster, V. (2005). Primary Prophylaxis With the Implantable Cardioverter-Defibrillator: The Need for Improved Risk Stratification. JAMA 294: 958-960 [Full Text]  
• Goodman, S. N (2005). Ethics and evidence in clinical trials. Clin Trials 2: 195-196  
• Mack, M. J., Nash, I., van Veldhuisen, D. J., Voors, A. A., Patwala, A., Schlosshan, D., Williams, S. G., Bardy, G. H., Lee, K. L., Mark, D. B., Kadish, A. H., McClellan, M. B., Tunis, S. R. (2005). Implantable Cardioverter-Defibrillators. NEJM 352: 2022-2025 [Full Text]  
• Pauker, S. G., Estes, N. A. M., Salem, D. N. (2005). Preventing Sudden Cardiac Death: Can We Afford the Benefit?. ANN INTERN MED 142: 664-666 [Full Text]  
• (2005). ICDs vs. Amiodarone for Patients with HF and LV Dysfunction. Journal Watch Cardiology 2005: 1-1 [Full Text]  
• (2005). Implantable Defibrillators -- Who Should Get Them?. JWatch General 2005: 1-1 [Full Text]  
• Kadish, A. (2005). Prophylactic Defibrillator Implantation -- Toward an Evidence-Based Approach. NEJM 352: 285-287 [Full Text]